Abstract
Clinical cases of C. auris noted during a COVID-19 surge led to an epidemiological, clinical, and genomic investigation. Evaluation identified a close genetic relationship but inconclusive epidemiologic link between all cases. Prolonged hospitalization due to critical illness from COVID-19 and use of antimicrobials may have contributed to clinical infections.
Original language | English (US) |
---|---|
Article number | e01146-21 |
Pages (from-to) | e0114621 |
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 65 |
Issue number | 10 |
DOIs | |
State | Published - Sep 17 2021 |
Keywords
- COVID-19
- Candida auris
- Outbreak investigation
- Whole-genome sequencing
- SARS-CoV-2
- Candidiasis, Invasive/drug therapy
- Humans
- Antifungal Agents/therapeutic use
- Candida/genetics
ASJC Scopus subject areas
- Pharmacology (medical)
- Infectious Diseases
- Pharmacology